close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

24.43 +0.01 (+0.04%)
Official Closing Price Updated: 7:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
The No. 1 Investing Mistake to Avoid As Washington Grinds to a Halt
Washington has shut down -- but don't fall into a panic, because these things don't last. 
Via The Motley Fool
Why The Pfizer-Trump Pharma Deal Is A Win For Branded Pharma, But Not For Consumers
The deal on drug prices between the US Administration and Pfizer will leave the margins of innovative pharma companies intact. 
Via Talk Markets
Down 50%, Should You Buy the Dip on Pfizer?
Pfizer's stock price is down materially from its 2021 highs, but it is also up notably from its April 2025 lows. 
Via The Motley Fool
Topics Intellectual Property
TrumpRx Brings Pfizer Into the Green—Is It a Buy?
Pfizer entered into a major agreement with the U.S. government to produce more affordable drugs for Americans. However, the stock’s outlook is still cloudy. 
Via MarketBeat
Topics Government
Viking Therapeutics Ignites Retail-Trader Frenzy Amid Deal Speculation, Upcoming Trial Catalysts
Via Stocktwits
Worried About Tariffs? 2 Safe Haven Stocks to Buy on the Dip With $500
Tariffs aren't likely to weigh on growth at these companies. 
Via The Motley Fool
Topics Government Stocks World Trade
Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal
Eli Lilly just got great news, courtesy of Pfizer and Trump, leading shares to their highest level in five months. Its rally may just be getting started. 
Via MarketBeat
Topics Government World Trade
Divergent Paths: Real Estate Stumbles While Healthcare Shines Amidst S&P 500's Record Ascent
As the S&P 500 and Nasdaq Composite continue their relentless climb to uncharted record highs in early October 2025, a fascinating and somewhat contradictory narrative is unfolding within the... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
U.S. Labor Market Stalls: Moody's Reports 'Essentially No Job Growth' Amidst Government Shutdown, Raising Recession Fears
Washington D.C., October 6, 2025 – The American labor market appears to have hit a significant speed bump, with Moody's Analytics reporting "essentially no job growth" for the U.S. in September 2025.... 
Via MarketMinute
Topics Artificial Intelligence Credit Cards Economy
From Defense To Pharma To Energy: Dividend Opportunities Across Sectors
Lockheed’s defense backlog, Pfizer’s biotech expansion, and Schlumberger’s energy contracts make for safe and potentially lucrative dividend plays heading into year-end. 
Via Talk Markets
Amgen To Offer Cholesterol Drug At 60% Discount As Trump Administration's Call To Lower Drug Prices
Amgen launches AmgenNow, offering Repatha at $239 per month, expanding direct access for U.S. patients with no insurer restrictions. 
Via Benzinga
Topics Government
Trump’s Drug Price Cuts: Boom or Bust for These 3 Pharma Giants
Trump’s drug price plan drove a Pfizer rally, leaves Eli Lilly buffered by U.S. investments, and could boost JNJ if it secures similar tariff relief. 
Via MarketBeat
Topics Government Supply Chain World Trade
Which S&P500 stocks are the most active on Monday?
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Monday and uncover the stocks that are leading the way in terms of trading volume and market... 
Via Chartmill
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
U.S. Tariff Barrage Rocks Global Markets: A Deep Dive into Trade Policy's Tremors
The global financial landscape has been significantly reshaped by a relentless wave of U.S. tariff announcements throughout 2025, sending shockwaves across major indices, currency markets, and... 
Via MarketMinute
Topics Economy Government Law Enforcement
AI Unlocks Secrets of Intrinsically Disordered Proteins: A Paradigm Shift in Biomedical Design
A groundbreaking advancement in artificial intelligence has opened new frontiers in understanding and designing intrinsically disordered proteins (IDPs), a class of biomolecules previously considered... 
Via TokenRing AI
Topics Artificial Intelligence Derivatives
Great News for Pfizer Stock Investors
Pharma stocks have been under pressure from the administration in 2025. 
Via The Motley Fool
Topics World Trade
3 Reasons to Buy Pfizer Stock Now
After years of underperformance, the future is looking brighter for the drugmaker. 
Via The Motley Fool
3 Dirt Cheap Stocks to Buy in a Market Priced for Perfection
Bargains can be found even when the stock market is arguably frothy. 
Via The Motley Fool
Topics Economy Government Intellectual Property
Can Pfizer's Stock Break This Disappointing Streak?
Pfizer's stock has been struggling for multiple years, and even a low valuation hasn't made it an enticing option for many investors. 
Via The Motley Fool
Topics Government Intellectual Property World Trade
Want $7,800 in Annual Passive Income? Invest $100,000 in These 3 Ultra-High-Yield Dividend Stocks.
These stocks can make your money work for you. 
Via The Motley Fool
Topics Energy Initial Public Offering
European Markets Soar: Healthcare and Mining Lead the Charge Amidst Dovish Fed and Robust Fundamentals
European financial markets are currently experiencing a period of remarkable strength, with major indices reaching or nearing all-time highs in early October 2025. This significant rally is largely... 
Via MarketMinute
Topics Artificial Intelligence Economy Electric Vehicles
European Equities Soar to Six-Month Highs as Rate Cut Hopes and Sectoral Strength Drive Rally
The European stock market has concluded its strongest week in five to six months, with the pan-European STOXX 600 index climbing a significant 2.8% by the week ending October 3, 2025. This robust... 
Via MarketMinute
Topics Economy World Trade
Pfizer’s AI Revolution: A New Era for Drug Discovery and Pharmaceutical Innovation
In a groundbreaking strategic pivot, pharmaceutical giant Pfizer (NYSE: PFE) is aggressively integrating artificial intelligence (AI), machine learning (ML), and advanced data science across its entire... 
Via TokenRing AI
Topics Artificial Intelligence Economy
US Government Shutdown Casts Global Shadow: Economic Data Delays Fuel Investor Uncertainty
The United States government is currently in the throes of a shutdown, commencing at 12:01 a.m. EDT on October 1, 2025, after a congressional impasse prevented the passage of appropriations legislation... 
Via MarketMinute
Topics Bonds Economy Government
Gold Shines Bright: Seven-Week Rally Fueled by Government Shutdown and Economic Instability Fears
Gold prices have surged for an unprecedented seventh consecutive week, reaching near-record highs as of October 3, 2025. This remarkable rally, with spot gold trading between $3,859.69 and $3,885.73... 
Via MarketMinute
Topics Bonds Economy Government
Wall Street Hits Record Highs As Rate Cut Bets Offset Shutdown: This Week In Markets
S&P500, Nasdaq100, Dow Jones, and Russell 2000 all hit record highs as investors focus on corporate optimism, monetary easing and AI tech. 
Via Benzinga
Topics Artificial Intelligence Stocks
Demystifying Pfizer: Insights From 4 Analyst Reviews
 
Via Benzinga
Data Blackout: Government Shutdown Leaves Fed Flying Blind Amidst Economic Crossroads
The U.S. economy finds itself at a critical juncture, navigating persistent inflation and a cooling labor market, while simultaneously grappling with the immediate and profound implications of an... 
Via MarketMinute
Topics Economy Energy Regulatory Compliance
Looking for the most active stocks in the S&P500 index on Friday?
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Friday and uncover the stocks that are leading the way in terms of trading volume and market... 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today